reiterateHDfinnhub
Keybanc Reiterates Sector Weight Rating on The Home Depot, Inc. (HD)
Keybanc reiterated its Sector Weight rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Keybanc reiterated its Sector Weight rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreArgus Research reiterated its Buy rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreMizuho reiterated its Outperform rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreDA Davidson reiterated its Buy rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreUBS reiterated its Buy rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreTruist Securities reiterated its Buy rating on The Home Depot, Inc. (NYSE:HD) on August 19, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Exxon Mobil Corporation (NYSE:XOM) on August 19, 2026.
Read moreNeedham reiterated its Buy rating on Streamex Corp. (NASDAQ:STEX) on August 18, 2026.
Read moreRosenblatt reiterated its Buy rating on SK Growth Opportunities Corporation (NASDAQ:SKGRU) on August 18, 2026.
Read moreBaird analysts downgraded Ramaco Resources, Inc. (NASDAQ:METC) from Outperform to Neutral on August 18, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Ramaco Resources, Inc. (NASDAQ:METC) on August 18, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) on August 18, 2026.
Read moreCitigroup reiterated its Buy rating on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) on August 18, 2026.
Read moreHC Wainwright & Co. reiterated its Neutral rating on BioMarin Pharmaceutical Inc.
Read moreBTIG reiterated its Buy rating on AVITA Medical, Inc. (NASDAQ:RCEL) on August 19, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Bowhead Specialty Holdings Inc. (NYSE:BOW) on August 19, 2026.
Read moreUBS analysts downgraded Core Natural Resources, Inc. (NYSE:CNR) from Buy to Neutral on August 19, 2026.
Read moreBMO Capital reiterated its Outperform rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on August 19, 2026.
Read moreWells Fargo reiterated its Overweight rating on Reinsurance Group of America, Incorporated (NYSE:RZB) on August 19, 2026.
Read moreBMO Capital analysts downgraded Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from Outperform to Market Perform on August 19, 2026.
Read more